Reduced peripheral brain-derived neurotrophic factor mRNA levels are normalized by antidepressant treatment

Research output: Contribution to journalArticle

Abstract

Consistent data coming from biochemical studies have evidenced a brain-derived neurotrophic factor (BDNF) serum reduction in depressed patients compared to controls and a restoration following antidepressant treatment. However, to date, no study has evaluated whether BDNF synthesis in leukocytes could contribute to such modulation. Therefore, in this study, we analysed BDNF mRNA levels in leukocytes from 21 depressed patients prior to and during escitalopram treatment and from 23 control subjects showing that BDNF mRNA levels were decreased in drug-free depressed patients and that 12 wk escitalopram treatment was able to reverse this deficit. Interestingly, changes in BDNF mRNA levels paralleled BDNF serum increase during antidepressant treatment, and were correlated with symptoms improvement. Our results indicate that BDNF serum modulation observed in depressed patients is associated with BDNF synthesis alteration in leukocytes and suggest that these peripheral cells might play an active role in the mechanisms of action of antidepressants.

Original languageEnglish
Pages (from-to)103-108
Number of pages6
JournalInternational Journal of Neuropsychopharmacology
Volume13
Issue number1
DOIs
Publication statusPublished - Feb 2010

Keywords

  • BDNF
  • Escitalopram
  • Leukocytes
  • Major depression
  • Serum

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology
  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Reduced peripheral brain-derived neurotrophic factor mRNA levels are normalized by antidepressant treatment'. Together they form a unique fingerprint.

  • Cite this